Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire February 24, 2023

LexaGene Holdings (TSXV:LXG) files for Chapter 7 bankruptcy

Trevor Abes  February 24, 2023

LexaGene Files for Chapter 7 Bankruptcy

GlobeNewswire February 24, 2023

IIROC Trading Halt - LXG

Canada NewsWire February 21, 2023

LexaGene Holdings Announces Results of February 8, 2023 Annual General Meeting

GlobeNewswire February 10, 2023

LexaGene Provides Update on BioPharma Sector

GlobeNewswire February 8, 2023

LexaGene's MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma Customers

GlobeNewswire January 18, 2023

BioPharma Engages LexaGene in Second Feasibility Study

GlobeNewswire December 16, 2022

LexaGene Holdings Proposes to Amend Warrants Terms

GlobeNewswire December 7, 2022

LexaGene (TSXV:LXG) completes a statement of work for BioPharma company

John Ballem  November 22, 2022

LexaGene Successfully Completes Statement of Work for BioPharma Company

GlobeNewswire November 22, 2022

LexaGene Closes Secured Convertible Note Transaction

GlobeNewswire November 1, 2022

LexaGene Holdings (TSXV:LXG) proposes to amend warrants terms

Azuka Onwuka October 28, 2022

LexaGene Holdings Proposes to Amend Warrants Terms

GlobeNewswire October 27, 2022

LexaGene Enters into Secured Convertible Note Agreement

GlobeNewswire October 24, 2022

LexaGene (TSXV:LXG) working with major biopharma company to validate technology

Jonathon Brown October 20, 2022

Large Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology Validation

GlobeNewswire October 20, 2022

LexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab System

GlobeNewswire October 13, 2022

LexaGene (TSXV:LXG) to sell its MiQLab System to a veterinary hospital in California

Jonathon Brown September 1, 2022

LexaGene Announces MiQLab® System Sale to Veterinary Hospital in California

GlobeNewswire September 1, 2022